Mary Salazar
Adult Health · San Antonio, TXNPI 1962592154
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Exelixis Inc. accounts for 63.9% of it on its own, with 31 other manufacturers making up the rest. Among adult health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $248.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$43K
- Incyte Corporation$20K
- AstraZeneca$1K
- Gilead$960
- Fresenius Kabi USA, LLC$582
- Astellas Pharma US Inc$171
- plus $1K from 26 others
What the payments were for
- Consulting fees$2,4804%
- Speaking & faculty fees$37,58055%
- Travel & lodging$23,26334%
- Food & beverage$4,1946%
- Education$2510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 146 | $43,302 |
| Incyte Corporation | 62 | $20,195 |
| AstraZeneca(2 entities) | 11 | $1,408 |
| Gilead | 3 | $960 |
| Fresenius Kabi USA, LLC | 2 | $582 |
| Astellas Pharma US Inc | 2 | $171 |
| Merck | 7 | $157 |
| Johnson & Johnson | 6 | $147 |
| Deciphera Pharmaceuticals Inc. | 1 | $120 |
| Lilly USA, LLC | 3 | $99 |
| Taiho Oncology, Inc. | 2 | $55 |
| Genentech USA, Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Bayer | 2 | $47 |
| Iovance Biotherapeutics, Inc. | 2 | $47 |
| Legend Biotech USA Inc. | 2 | $43 |
| Novartis | 2 | $40 |
| Amgen | 2 | $37 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| Pfizer | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Geron Corporation | 1 | $18 |
| Mirum Pharmaceuticals, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
| Pharmaand GmbH | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$67,768 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 11 | $232 |
| Ondansetron Hcl | 11 | $177 |
Paid to pharmacies, not to this prescriber.
Other adult health in San Antonio
- Lafitte HolmesSan Antonio$13K
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Sandra CareyGrapevine$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.